Last week's chemistry & life sciences news headlines

SelectScience office at selectscience.net
Wed Oct 6 09:41:34 EST 1999


Last week, www.selectscience.net reported
on 19 news stories the day they happened,
so if you need to keep up to speed on
the latest business developments in
chemistry and life science, make the news
ticker on www.selectscience.net part of
your daily routine.

Andrew Smith (andrew at selectscience.net)
Editor, www.selectscience.net

Last week's headlines were:


Genset and Janssen identify a novel candidate gene associated with
schizophrenia

Nova Molecular Inc. appoint Margaret Bywater as President, CEO & CSO

Gemini appoints Dr Roberto Rosenkranz as a non-executive director

DuPont Plans to Acquire CombiChem To Assist in Drug Discovery

Incyte and Millennium Enter Into Genomic Database and Bioinformatics
Partnership

Lexicon Genetics Announces Database Agreement With Millennium
Pharmaceuticals

ChemBridge Corporation Enters Combinatorial Chemistry Agreement with Roche

How State and Local Government Can Grow the Life Sciences Industry

Genentech Chairman/CEO Arthur Levinson receives Irvington Institute's
Corporate Leadership

Alpharma appoints Ms. Nancy V. Ryan Vice President of Human Resources

Merck Pharma Division establishes strong presence in United States, names
new global Management Board

Genentech appoints Daniel S. Sulzbach to Vice President, Information
Resources

Genzyme Molecular Oncology Licenses Antisense Cancer Rights to Hybridon

Isis and Rhone-Poulenc Rorer Establish Antisense Target Validation
Collaboration

Abbott Laboratories in Discussion with the Food and Drug Administration
Regarding Compliance Issues in Diagnostics Division

Revised UK BioIndustry Association Code of Best Practice

Scientists unveil plastic plants

Dupont Pharmaceuticals, Janssen Pharmaceutica and Neurocrine Biosciences
enter into CRF agreement

Trega Biosciences announces management addition and new business
developments






More information about the Dros mailing list